Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug?

Quatraro A, Consoli G, Magno M, Caretta F, Nardozza A, Ceriello A, Giugliano D.

Ann Intern Med. 1990 May 1;112(9):678-81.

PMID:
2110430
[PubMed - indexed for MEDLINE]
2.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
3.

Comparative efficacy of metformin and glibenclamide in patients with non-insulin-dependent diabetes mellitus.

Hermann LS, Bitzén PO, Kjellström T, Lindgärde F, Scherstén B.

Diabete Metab. 1991 May;17(1 Pt 2):201-8.

PMID:
1936477
[PubMed - indexed for MEDLINE]
5.

Effects of two different glibenclamide dose-strengths in the fixed combination with metformin in patients with poorly controlled T2DM: a double blind, prospective, randomised, cross-over clinical trial.

Brunetti P, Pagano G, Turco C, Gori M, Perriello G; Glibo 5 Study Group.

Diabetes Nutr Metab. 2004 Dec;17(6):350-7.

PMID:
15887629
[PubMed - indexed for MEDLINE]
6.

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

Chiasson JL, Josse RG, Hunt JA, Palmason C, Rodger NW, Ross SA, Ryan EA, Tan MH, Wolever TM.

Ann Intern Med. 1994 Dec 15;121(12):928-35.

PMID:
7734015
[PubMed - indexed for MEDLINE]
7.

Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: an 18-week, randomized, open-label study.

Raz I, Stranks S, Filipczak R, Joshi P, Lertoft B, Rastam J, Chow CC, Shaban J.

Clin Ther. 2005 Sep;27(9):1432-43.

PMID:
16291416
[PubMed - indexed for MEDLINE]
8.

Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.

Mattoo V, Eckland D, Widel M, Duran S, Fajardo C, Strand J, Knight D, Grossman L, Oakley D, Tan M; H6E-MC-GLAT study group.

Clin Ther. 2005 May;27(5):554-67.

PMID:
15978304
[PubMed - indexed for MEDLINE]
9.

Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.

Avilés-Santa L, Sinding J, Raskin P.

Ann Intern Med. 1999 Aug 3;131(3):182-8.

PMID:
10428734
[PubMed - indexed for MEDLINE]
10.

Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation.

Falko JM, Osei K.

Am J Med. 1985 Sep 20;79(3B):92-101.

PMID:
3931467
[PubMed - indexed for MEDLINE]
11.

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

[No authors listed]

Lancet. 1998 Sep 12;352(9131):854-65. Erratum in: Lancet 1998 Nov 7;352(9139):1558.

PMID:
9742977
[PubMed - indexed for MEDLINE]
12.

Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.

Ponssen HH, Elte JW, Lehert P, Schouten JP, Bets D.

Clin Ther. 2000 Jun;22(6):709-18.

PMID:
10929918
[PubMed - indexed for MEDLINE]
13.
14.

Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.

Roach, Koledova E, Metcalfe S, Hultman C, Milicevic Z; Romania/Russia Mix25 Study Group.

Clin Ther. 2001 Oct;23(10):1732-44.

PMID:
11726007
[PubMed - indexed for MEDLINE]
16.
17.

Nateglinide and glibenclamide metabolic effects in naïve type 2 diabetic patients treated with metformin.

Derosa G, D'Angelo A, Fogari E, Salvadeo S, Gravina A, Ferrari I, Cicero AF.

J Clin Pharm Ther. 2009 Feb;34(1):13-23. doi: 10.1111/j.1365-2710.2008.00984.x.

PMID:
19125899
[PubMed - indexed for MEDLINE]
19.
20.

Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.

Rosenstock J, Rood J, Cobitz A, Biswas N, Chou H, Garber A.

Diabetes Obes Metab. 2006 Nov;8(6):650-60.

PMID:
17026489
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk